{
    "title": "Pfizer's $11.6 bln Biohaven buy could spark more biotech deals",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10806523/Pfizers-11-6-bln-Biohaven-buy-spark-biotech-deals.html",
    "date": "2022-05-11",
    "keywords": [
        "cash",
        "sector",
        "deal",
        "analyst",
        "inc",
        "biontech",
        "migraine",
        "specialist",
        "wall",
        "street",
        "cashflush",
        "tuesday",
        "year",
        "dearth",
        "investor",
        "easing",
        "biotech",
        "weight",
        "lack",
        "mampa",
        "news",
        "doctor",
        "piper",
        "sandler",
        "christopher",
        "raymond",
        "april",
        "crash",
        "valuation",
        "crunch",
        "february",
        "acquisition",
        "target",
        "biotechnology",
        "comment",
        "pfizer",
        "premium",
        "share",
        "price",
        "october",
        "selloff",
        "covid19",
        "moderna",
        "quarter",
        "position",
        "shift",
        "point",
        "merck",
        "co",
        "officer",
        "robert",
        "davis",
        "month",
        "movement",
        "reporting",
        "bengaluru",
        "editing",
        "banerjee",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}